Elevance Health Inc
ELV
View Detailed Chart
317.860USD
-4.090-1.27%
Market hours （ET）Quotes delayed by 15 min
70.58BMarket Cap
12.76P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.27%
5 Days
-8.21%
1 Month
-1.63%
6 Months
-24.42%
Year to Date
-13.84%
1 Year
-22.62%
View Detailed Chart
TradingKey Stock Score of Elevance Health Inc
Currency: USD Updated: 2025-10-30Key Insights
The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Elevance Health Inc's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
25
analysts
Buy
Current Rating
386.153
Target Price
+14.80%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Elevance Health Inc Highlights
StrengthsRisks
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 176.81B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 25.38%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 25.38%.
Undervalued
The company’s latest PE is 13.09, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 209.27M shares, decreasing 3.54% quarter-over-quarter.
Held by Glenn Greenberg
Star Investor Glenn Greenberg holds 1.11M shares of this stock.
Financial Indicators
EPS
No Data
Total revenue
No Data
Elevance Health Inc Info
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
Ticker SymbolELV
CompanyElevance Health Inc
CEOMs. Gail K. Boudreaux
Websitehttps://www.elevancehealth.com/
Related Instruments
Popular Symbols
